"Galantamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.
Descriptor ID |
D005702
|
MeSH Number(s) |
D03.132.052.500 D03.633.100.079.525
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Galantamine".
Below are MeSH descriptors whose meaning is more specific than "Galantamine".
This graph shows the total number of publications written about "Galantamine" by people in this website by year, and whether "Galantamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Galantamine" by people in Profiles.
-
COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway. Med Hypotheses. 2020 12; 145:110331.
-
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning. Curr Pharm Des. 2019; 25(33):3519-3535.
-
Changes in electrophysiological markers of cognitive control after administration of galantamine. Neuroimage Clin. 2018; 20:228-235.
-
Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors. Alzheimers Dement. 2017 Oct; 13(10):1098-1106.
-
FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease. Clin Interv Aging. 2014; 9:1783-91.